|Leading policy-makers and scholars explain how market forces, deregulation, and consumer choice can work to improve health care for all Americans.||
The Reimportation Blues
The CATO Institute’s Roger Pilon made a splash earlier this year by releasing a report arguing in favor of reimportation on free trade grounds. In this op-ed, he modifies that argument slightly by noting the lead reimportation bill – the Dorgan-Snowe proposal – would prevent free trade by barring companies from limiting supplies to countries that impose price controls. He notes that this bill would effectively import foreign price controls rather than let the market decide what the world price of drugs ought to be, and as such is a bad idea.
|home spotlight commentary research events news about contact links archives|